FATE THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fate Therapeutics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Fate Therapeutics Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $58.4M, a 6.82% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $58.4M -$4.28M -6.82% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $59.5M -$4.2M -6.58% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $60.6M -$4.06M -6.28% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $61.7M -$4.39M -6.65% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $62.7M -$4.66M -6.91% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $63.7M -$4.75M -6.94% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $64.7M -$4.79M -6.9% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $66.1M -$4.65M -6.58% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $67.4M +$2.41M +3.71% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $68.5M +$2.31M +3.49% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $69.5M +$2.18M +3.24% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $70.7M +$3.64M +5.42% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $65M -$2.16M -3.22% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $66.2M -$2.05M -3% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $67.3M -$1.91M -2.75% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $67.1M +$44.3M +195% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $67.1M +$44M +190% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $68.2M +$44.7M +190% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $69.2M +$45.2M +189% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $22.8M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $23.2M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $23.6M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $24M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.